These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 174412)

  • 1. Murine cytomegalovirus (MCMV).
    Lussier G
    Adv Vet Sci Comp Med; 1975; 19():223-47. PubMed ID: 174412
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
    Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
    Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression reactivates and disseminates latent murine cytomegalovirus.
    Jordan MC; Shanley JD; Stevens JG
    J Gen Virol; 1977 Nov; 37(2):419-23. PubMed ID: 200714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of ocular murine cytomegalovirus infection.
    Hayashi K; Kurihara I; Uchida Y
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):486-93. PubMed ID: 2984137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine cytomegalovirus ocular infection in immunocompetent and cyclophosphamide-treated mice. Potentiation of ocular infection by cyclophosphamide.
    Bale JF; O'Neil ME; Folberg R
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1749-56. PubMed ID: 1851731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrotizing retinopathy after intraocular inoculation of murine cytomegalovirus in immunosuppressed adult mice.
    Holland GN; Fang EN; Glasgow BJ; Zaragoza AM; Siegel LM; Graves MC; Saxton EH; Foos RY
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2326-34. PubMed ID: 2173685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection and disease in children: present state of knowledge.
    Diosi P
    Rev Roum Inframicrobiol; 1971; 8(4):217-21. PubMed ID: 4340443
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of T cells in mouse cytomegalovirus myocarditis.
    Lawson CM; O'Donoghue H; Reed WD
    Immunology; 1989 May; 67(1):132-4. PubMed ID: 2544512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies.
    Bartholomaeus WN; O'Donoghue H; Foti D; Lawson CM; Shellam GR; Reed WD
    Immunology; 1988 Jul; 64(3):397-405. PubMed ID: 2842252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of exogenous interferon on neonatal infection with murine cytomegalovirus.
    Cruz JM; Waner JL; Dammin GJ
    IARC Sci Publ (1971); 1978; (24 Pt 2):1067-71. PubMed ID: 221374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerulonephritis caused by murine cytomegalovirus. Potentiation by antithymocyte serum.
    Lussier G
    Vet Pathol; 1976; 13(2):123-30. PubMed ID: 180651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus.
    Reddehase MJ; Keil GM; Koszinowski UH
    J Immunol; 1984 Jan; 132(1):482-9. PubMed ID: 6317749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated cytomegalovirus disease in the guinea pig.
    Van Hoosier GL; Giddens WE; Gillett CS; Davis H
    Lab Anim Sci; 1985 Feb; 35(1):81-4. PubMed ID: 2984460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of cytomegalovirus: immunosuppressive effects during infections.
    Ho M
    Birth Defects Orig Artic Ser; 1984; 20(1):131-47. PubMed ID: 6203569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
    Rölle A; Olweus J
    APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncogenic potential of human cytomegalovirus.
    Spector DH; Spector SA
    Prog Med Virol; 1984; 29():45-89. PubMed ID: 6322235
    [No Abstract]   [Full Text] [Related]  

  • 18. The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.
    Hudson JB
    Arch Virol; 1979; 62(1):1-29. PubMed ID: 231945
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo reactivation of latent murine cytomegalovirus in the eye by immunosuppressive treatment.
    Rabinovitch T; Oh JO; Minasi P
    Invest Ophthalmol Vis Sci; 1990 Apr; 31(4):657-63. PubMed ID: 2159448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of murine cytomegalovirus in murine Y-1 cells.
    Shanley JD; Lutwick LI; Donta ST
    J Med Virol; 1979; 4(4):261-8. PubMed ID: 232142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.